SCHOTT Pharma AG & Co KgaA
F:1SXP
SCHOTT Pharma AG & Co KgaA
F:1SXP
Price:
14.02
EUR
-1.13%
Market Closed
Market Cap:
€2.1B
Cash Flow Statement
Cash Flow Statement
SCHOTT Pharma AG & Co KgaA
SCHOTT Pharma AG & Co KgaA
Currency: EUR
| Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
152
|
196
|
222
|
151
|
150
|
135
|
148
|
147
|
147
|
|
| Depreciation & Amortization |
47
|
61
|
77
|
61
|
65
|
69
|
72
|
75
|
79
|
|
| Change in Deffered Taxes |
1
|
4
|
(5)
|
(12)
|
(4)
|
(10)
|
0
|
6
|
2
|
|
| Other Non-Cash Items |
(2)
|
(22)
|
(2)
|
(6)
|
(2)
|
2
|
(7)
|
(1)
|
2
|
|
| Cash Taxes Paid |
32
|
41
|
48
|
39
|
30
|
29
|
35
|
51
|
51
|
|
| Cash Interest Paid |
7
|
9
|
11
|
9
|
11
|
13
|
15
|
16
|
16
|
|
| Change in Working Capital |
(16)
|
7
|
(18)
|
(1)
|
16
|
(12)
|
(7)
|
(24)
|
(51)
|
|
| Cash from Operating Activities |
182
N/A
|
248
+36%
|
273
+10%
|
193
-29%
|
225
+17%
|
183
-18%
|
206
+12%
|
204
-1%
|
180
-12%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(176)
|
(204)
|
(232)
|
(170)
|
(145)
|
(138)
|
(139)
|
(153)
|
(145)
|
|
| Other Items |
4
|
4
|
4
|
3
|
(110)
|
(0)
|
1
|
(1)
|
(14)
|
|
| Cash from Investing Activities |
(171)
N/A
|
(200)
-17%
|
(229)
-14%
|
(166)
+27%
|
(255)
-54%
|
(138)
+46%
|
(139)
-1%
|
(155)
-12%
|
(159)
-2%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Debt |
(3)
|
(4)
|
(5)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
|
| Cash Paid for Dividends |
(19)
|
0
|
(41)
|
(42)
|
(23)
|
0
|
(25)
|
(24)
|
(24)
|
|
| Other |
11
|
(28)
|
(4)
|
23
|
58
|
(20)
|
(29)
|
(14)
|
8
|
|
| Cash from Financing Activities |
(11)
N/A
|
(51)
-347%
|
(50)
+2%
|
(21)
+57%
|
32
N/A
|
(48)
N/A
|
(59)
-23%
|
(43)
+27%
|
(21)
+51%
|
|
| Change in Cash | ||||||||||
| Effect of Foreign Exchange Rates |
(3)
|
(4)
|
(4)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
|
| Net Change in Cash |
(4)
N/A
|
(7)
-68%
|
(10)
-31%
|
3
N/A
|
(1)
N/A
|
(5)
-309%
|
7
N/A
|
4
-40%
|
(1)
N/A
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
6
N/A
|
44
+612%
|
41
-6%
|
23
-44%
|
79
+248%
|
46
-42%
|
67
+46%
|
50
-25%
|
35
-30%
|
|
Switch to:
Switch to:
See Also
Discover More
